Alnylam Pharmaceuticals
ALNY
#544
Rank
โ‚ฌ37.62 B
Marketcap
284,78ย โ‚ฌ
Share price
-2.52%
Change (1 day)
6.30%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company